Cloning pets goes commercial in US
A California company which cloned the world’s first cat nearly three years ago is starting to fill orders for cloned pets. Genetic Savings and Clone recently produced Bengal kittens Tabouli and Baba Ganoush. Now five customers are paying US$50,000 each for a clone of their cats, which should be ready by December. And several hundred clients are paying $150 a year plus an initial $900 to preserve tissue for future cloning. Critics say that the company is exposing animals to risks without any benefits. “The quest for immortality in ourselves and even in our pets opens the door to commercial interests who want to make a profit on it,” says David Magnus, a Stanford bioethicist. However, the company is offering customers their money back or a new clone if their cloned pet has any defects.
Latest posts by Mumbai (see all)
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
A painful debate: shrinking the carbon footprint of anaesthetics
If there is any profession which seems remote from the Sturm und Drang of climate change, it must be anaesthetists....
Some patients recall death experiences after heart attacks
In an article in the journal Resuscitation, some survivors of cardiac arrest have described lucid death experiences that occurred while...
Queensland widower dies after taking assisted suicide drugs ordered by his wife
“Move along, please. Nothing to see here.” This was more or less the reaction of supporters of “voluntary assisted dying”...
Australian first: nurse donates organs after euthanasia
A Victorian woman has become the first Australian to combine death by euthanasia with organ donation. Ballarat nurse Marlene Bevern,...
Canadian study hints at crushing institutional conscience objections to ‘assisted dying’
Supporters of “voluntary assisted dying” fought hard to achieve legalisation in various jurisdictions around the world. After legalisation, however, battles...
Hope, hype and xenotransplantation
On January 7, 2022 David Bennett, a 57-year-old with terminal heart disease, made history as the first person to receive...